Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Immuno-Oncology Congress 2022: Industry Sponsored Satellite Symposia

ESMO-Immuno-Oncology-2022-1000x250

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Wednesday 7 December

Current and Future Roles of Immunotherapy in the Treatment of Advanced BCC and CSCC

01-Current-and-Future-Roles-of-Immunotherapy-in-the-Treatment-of-Advanced-BCC-and-CSCC-SANOFI-thumb

Wednesday, 17:45 - 18:45
View the satellite invitation

Thursday 8 December

Exploring New Advancements in Chemokine Signaling in Tumor Biology: Focus on IL-8, CXCR1, and CXCR2

02-Exploring-New-Advancements-in-Chemokine-Signaling-in-Tumor-Biology-Focus-on-IL-8-CXCR1-and-CXCR2-BMS-thumb

Thursday, 13:15 - 14:15
View the satellite invitation

Utilizing Immunohistochemistry Testing, Biomarkers, and Targeted Therapeutics to Optimize Outcomes in Patients with NSCLC

03-Utilizing-Immunohistochemistry-Testing-Biomarkers-and-Targeted-Therapeutics-to-Optimize-Outcomes-in-thumb.jpg

Thursday, 17:45 - 18:45
View the satellite invitation

Friday 9 December

The Need to Advance Checkpoint Blockade for Cancer Immunotherapy and the Potential Role of the CD226 Axis

04-The-Need-to-Advance-Checkpoint-Blockade-for-Cancer-Immunotherapy-and-the-Potential-Role-of-the-CD226-Axis-thumb

Friday, 13:15 - 14:15
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.